NEWS
All News
FDA Briefs
Oncology Icons
Special Reports
The Targeted Pulse
Voices from the Field
CONFERENCES
Conference Coverage
Conference Listing
Data Dialogue with the Oncology Brothers
MEDIA
All Videos
Case-Based Peer Perspectives
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
Medical World News
Pivotal Practice Views with the Oncology Brothers
Podcasts
Precision Medicine
Speaking Out
PUBLICATIONS
All Publications
Evolving Paradigms
Peers & Perspectives in Oncology
Targeted Therapies in Oncology
CASE-BASED ROUNDTABLE
PARTNERS
RESOURCES
CME/CE
Clinical Trials
Precision Medicine Perspectives
Press Releases
Sponsored Content
Treatment Resources
SUBSCRIBE
Choose Specialty
BRAIN CANCER
BREAST CANCER
BREAST CANCER
GENITOURINARY CANCERS
GENITOURINARY CANCERS
GENITOURINARY CANCERS
GENITOURINARY CANCERS
GENOMIC TESTING
GENOMIC TESTING
GI CANCERS
GI CANCERS
GI CANCERS
GI CANCERS
GI CANCERS
GYNECOLOGIC CANCERS
GYNECOLOGIC CANCERS
GYNECOLOGIC CANCERS
GYNECOLOGIC CANCERS
HEAD & NECK CANCERS
HEMATOLOGY
HEMATOLOGY
IMMUNOTHERAPY
IMMUNOTHERAPY
LEUKEMIAS
LEUKEMIAS
LEUKEMIAS
LEUKEMIAS
LUNG CANCER
LUNG CANCER
LUNG CANCER
LUNG CANCER
LUNG CANCER
LYMPHOMAS
LYMPHOMAS
LYMPHOMAS
LYMPHOMAS
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
SARCOMA
SKIN CANCERS
SKIN CANCERS
THYROID CANCERS
Spotlight -
Biomarker-Driven Lung Cancer
GIST
HER2 Breast Cancer
Chronic Lymphocytic Leukemia
Small Cell Lung Cancer
Renal Cell Carcinoma
Choose Specialty
BRAIN CANCER
BREAST CANCER
BREAST CANCER
GENITOURINARY CANCERS
GENITOURINARY CANCERS
GENITOURINARY CANCERS
GENITOURINARY CANCERS
GENOMIC TESTING
GENOMIC TESTING
GI CANCERS
GI CANCERS
GI CANCERS
GI CANCERS
GI CANCERS
GYNECOLOGIC CANCERS
GYNECOLOGIC CANCERS
GYNECOLOGIC CANCERS
GYNECOLOGIC CANCERS
HEAD & NECK CANCERS
HEMATOLOGY
HEMATOLOGY
IMMUNOTHERAPY
IMMUNOTHERAPY
LEUKEMIAS
LEUKEMIAS
LEUKEMIAS
LEUKEMIAS
LUNG CANCER
LUNG CANCER
LUNG CANCER
LUNG CANCER
LUNG CANCER
LYMPHOMAS
LYMPHOMAS
LYMPHOMAS
LYMPHOMAS
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
SARCOMA
SKIN CANCERS
SKIN CANCERS
THYROID CANCERS
Spotlight
NEWS
CONFERENCES
MEDIA
PUBLICATIONS
CASE-BASED ROUNDTABLE
PARTNERS
RESOURCES
SUBSCRIBE
Advertisement
Bispecifics: Operationalizing Administration and Follow-Up
: Episode 1
Introduction to Bispecific Antibodies: Operationalizing Administration and Follow-Up
December 13, 2023
By
Justin LaPorte, PharmD, BCOP
Opinion
Video
Justin LaPorte, PharmD, BCOP, introduces the purpose and objectives for the program.
Now Viewing
EP: 1.
Introduction to Bispecific Antibodies: Operationalizing Administration and Follow-Up
EP: 2.
Overview of Bispecific Engagers Administration Program
EP: 3.
Program Development and SOPs for Bispecific Engagers
EP: 4.
Treating Patients With Bispecific Engagers
EP: 5.
The Grading and Management of Early and Late Adverse Events
EP: 6.
How Administration of Bispecific T-Cell Engagers Has Evolved
EP: 7.
Closing Remarks on Bispecific Antibodies
Recent Videos
Related Content
Related Content